Delivery Order SPE2DB24D9131-SPE2DB25FXRW3
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at approximately $37,000 by the Defense Logistics Agency on August 25, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 5, 2025. The delivery order, which expires August 6, 2025, is for Trikafta 100-50-75 mg/150 mg pharmaceutical products. This award was issued without a set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $110,928.72 by the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The delivery order, which is set to be completed by July 22, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg capsules (84-count units). This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on July 26, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,754.56 by the Defense Logistics Agency on September 11, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This award leverages DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $111,757.17 by the Defense Logistics Agency (DLA) on September 17, 2025. The contract, which has no set-aside designation, calls for the delivery of Trikafta 100-50-75 mg/150 mg tablets in quantities of 84 units. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on September 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of September 9, 2025, and represents no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,314.19 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Trikafta 80-40-60mg/59.5mg packets (14-count). This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a continuation of DMS Pharmaceutical Group's role as a critical pharmaceutical supplier to the federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,316.57 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, was issued without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $18,488.12 from the Defense Logistics Agency (DLA) on September 12, 2025. The delivery order, which is expected to be completed by September 15, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB25FXRW3Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,316.57 by the Defense Logistics Agency on September 26, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets (14-count). This delivery order represents one of numerous pharmaceutical product deliveries issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million through November 2026. The contract carries no set-aside designation, allowing the vendor to compete on equal footing in the federal procurement marketplace. The product is scheduled for delivery to the company's headquarters location in Park Ridge, Illinois, with an ultimate completion date of September 29, 2025. This award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare system. The company's IDC vehicle with the Defense Logistics Agency enables the issuance of firm fixed-price delivery orders across an extensive portfolio of pharmaceutical items, including prescription medications, biologics, and medical consumables supporting military health facilities nationwide. DMS Pharmaceutical Group's consistent success in securing federal pharmaceutical contracts demonstrates its capacity to reliably distribute branded and generic drugs, vaccines, and specialty medications essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 9/26/25 |